medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»medalphabet-881Research ArticleСтатьиПоражение периферической нервной системы при сахарном диабетеDamage to peripheral nervous system in diabetes mellitusКамчатновП. Р.KamchatnovP. R.noemail@neicon.ruЧугуновА. В.ChugunovA. V.noemail@neicon.ruЕвзелъманМ. А.EvzelmanM. A.noemail@neicon.ruФГБОУ ВО «Российский национальный исследовательский медицинский университет имени Н. И. Пирогова» Минздрава РоссииРоссияRussian National Research Medical University n.a. N. I. PirogovRussian FederationФГБОУ ВО «Орловский государственный университет имени И. С. Тургенева»РоссияOrel State University named after I. S. TurgenevRussian Federation201825102018433Неврология и психиатрия2933Copyright © Камчатнов П.Р., Чугунов А.В., Евзелъман М.А., 20182018Камчатнов П.Р., Чугунов А.В., Евзелъман М.А.Kamchatnov P.R., Chugunov A.V., Evzelman M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/881

Поражение периферической нервной системы - одно из наиболее частых осложнений сахарного диабета. Наиболее тяжелая форма - вегетативная диабетическая полинейропатия (ВДПН), ассоциированная с риском стойкой инвалидизации и наступления летального исхода, значительным снижением качества жизни пациентов. Рассматриваются возможности диагностики ВДПН в условиях клинической практики. Анализируются современные подходы к лечению пациентов с ВДПН, включая препараты, нормализующие обмен веществ в нервной ткани, а также устраняющие основные симптомы заболевания.

The defeat of the peripheral nervous system is one of the most frequent complications of diabetes. The most severe form is vegetative diabetic polyneuropathy (VDPN), associated with the risk of persistent disability and the onset of death, a significant reduction in the quality of life of patients. The possibilities of diagnosing VDPN in clinical practice are considered. Modern approaches to the treatment of patients with VDPN, including drugs that normalize the metabolism in the nervous tissue, as well as eliminating the main symptoms of the disease are analyzed.

сахарный диабетдиабетическая полинейропатиявегетативная диабетическая полинейропатиялечениеdiabetes mellitusdiabetic polyneuropathyautonomic diabetic polyneuropathytreatmentReferencesГурьева И. В., Левин О. С. Диабетическая полинейропатия // Consilium medicum. 2014. № 4. С. 12-16.Гурьева И. В., Левин О. С. Диабетическая полинейропатия // Consilium medicum. 2014. № 4. С. 12-16.Левин О. С. Полиневропатия. М.: МИА, 2006.- 496 с.Левин О. С. Полиневропатия. М.: МИА, 2006.- 496 с.Ahlqvist E., van Zuydam N., Groop L., McCarthy M. The genetics of diabetic complications / Nat Rev Nephrol. 2015. N 11 (5). Р. 277-87.Ahlqvist E., van Zuydam N., Groop L., McCarthy M. The genetics of diabetic complications / Nat Rev Nephrol. 2015. N 11 (5). Р. 277-87.Callaghan B., Hur J., Feldman E. Diabetic neuropathy: one disease or two? Curr Opin Neurol. 2012. N25(5). Р. 536-41.Callaghan B., Hur J., Feldman E. Diabetic neuropathy: one disease or two? Curr Opin Neurol. 2012. N25(5). Р. 536-41.Callaghan B., Little A., Feldman E., Hughes R. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012 Jun 13; 6: CD 007543.Callaghan B., Little A., Feldman E., Hughes R. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012 Jun 13; 6: CD 007543.Carandang M., Takamatsu N., Nodera H. et al. Velocity of intraneural blood flow is increased in inflammatory neuropathies: sonographic observation // J Neurol Neurosurg Psychiatry. 2016. N54. Р. 54-58.Carandang M., Takamatsu N., Nodera H. et al. Velocity of intraneural blood flow is increased in inflammatory neuropathies: sonographic observation // J Neurol Neurosurg Psychiatry. 2016. N54. Р. 54-58.Cha S.-A., Yun J.-S., Lim T.-S. et al. Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes // PLOS ONE. D0I:10.1371/journal.pone.0164807.Cha S.-A., Yun J.-S., Lim T.-S. et al. Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes // PLOS ONE. D0I:10.1371/journal.pone.0164807.Cohen J., Estacio R., Lundgren R. et al. Diabetic autonomic neuropathy is associated with an increased incidence of strokes // Autonomic Neuroscience. 2003. № 108 (1-2). Р. 73-78.Cohen J., Estacio R., Lundgren R. et al. Diabetic autonomic neuropathy is associated with an increased incidence of strokes // Autonomic Neuroscience. 2003. № 108 (1-2). Р. 73-78.Duby J., Campbell K., Setter S. et al. Diabetic Neuropathy: An Intensive Review // Am J Health-Syst Pharm. 2004. N61 (2). Р.160-176.Duby J., Campbell K., Setter S. et al. Diabetic Neuropathy: An Intensive Review // Am J Health-Syst Pharm. 2004. N61 (2). Р.160-176.Freccero C., Svensson H., Bornmyr S., Wollmer P. et al. Sympathetic and parasympathetic neuropathy are frequent in both type 1 and type 2 diabetic patients // Diabetes Care. 2004. N27 (12). Р. 2936-41.Freccero C., Svensson H., Bornmyr S., Wollmer P. et al. Sympathetic and parasympathetic neuropathy are frequent in both type 1 and type 2 diabetic patients // Diabetes Care. 2004. N27 (12). Р. 2936-41.Gatopoulou A., Papanas N., Maltezos E. Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice // Eur J Intern Med. 2012. N23 (6). Р. 499-505.Gatopoulou A., Papanas N., Maltezos E. Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice // Eur J Intern Med. 2012. N23 (6). Р. 499-505.Hage F., Iskandrian A. Cardiac Autonomic Denervation in Diabetes Mellitus // Circulation: Cardiovascular Imaging. 2011. N4. Р. 79-81.Hage F., Iskandrian A. Cardiac Autonomic Denervation in Diabetes Mellitus // Circulation: Cardiovascular Imaging. 2011. N4. Р. 79-81.Hanewinckel R., Drenthen J., Ligthart S. et al. Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study // J Neurol Neurosurg Psychiatry. 2016. N87. Р. 1336-1342.Hanewinckel R., Drenthen J., Ligthart S. et al. Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study // J Neurol Neurosurg Psychiatry. 2016. N87. Р. 1336-1342.Jin H. Y., Baek H. S., Park T. S. Morphologic Changes in Autonomic Nerves in Diabetic Autonomic Neuropathy // Diabetes Metab J. 2015. № 39 (6). Р. 461-467.Jin H. Y., Baek H. S., Park T. S. Morphologic Changes in Autonomic Nerves in Diabetic Autonomic Neuropathy // Diabetes Metab J. 2015. № 39 (6). Р. 461-467.Koo B. Screening of autonomic neuropathy in patients with type2 diabetes // Diabetes Metab J. 2014. 38. Р. 346-348.Koo B. Screening of autonomic neuropathy in patients with type2 diabetes // Diabetes Metab J. 2014. 38. Р. 346-348.Lоseth S., Stеlberg E., Lindal S. Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study // Journal of the Peripheral Nervous System. 2016. № 21. Р. 15-21.Lоseth S., Stеlberg E., Lindal S. Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study // Journal of the Peripheral Nervous System. 2016. № 21. Р. 15-21.Mazokopakis E., Starakis I. Recommendations for diagnosis and management of metformin-induced vitamin B 12 (Cbl) deficiency // Diabetes Res Clin Pract. 2012. № 97 (3). Р. 359-67.Mazokopakis E., Starakis I. Recommendations for diagnosis and management of metformin-induced vitamin B 12 (Cbl) deficiency // Diabetes Res Clin Pract. 2012. № 97 (3). Р. 359-67.Papanas N., Ziegler D. Prediabetic neuropathy: does it exist? // Curr Diab Rep. 2012. N 12 (4). Р. 376-83.Papanas N., Ziegler D. Prediabetic neuropathy: does it exist? // Curr Diab Rep. 2012. N 12 (4). Р. 376-83.Petrofsky J, Berk L., Al-Nakhli H. The Influence of Autonomic Dysfunction Associated with Aging and Type 2 Diabetes on Daily Life Activities // Experimental Diabetes Research. 2012. N 12. Р. 34-39.Petrofsky J, Berk L., Al-Nakhli H. The Influence of Autonomic Dysfunction Associated with Aging and Type 2 Diabetes on Daily Life Activities // Experimental Diabetes Research. 2012. N 12. Р. 34-39.Reljanovic M., Reichel G., Rett K. et al. The ALADIN II Study Group: Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two-year multicenter randomized double blind placebo contorolled trial (ALADIN II) // Free Radic Res. 1999. N 31. Р. 171-179.Reljanovic M., Reichel G., Rett K. et al. The ALADIN II Study Group: Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two-year multicenter randomized double blind placebo contorolled trial (ALADIN II) // Free Radic Res. 1999. N 31. Р. 171-179.Smith A., Ramachandran P., Tripp S., Singleton J. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy // Neurology. 2001. N57. Р. 1701-1704.Smith A., Ramachandran P., Tripp S., Singleton J. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy // Neurology. 2001. N57. Р. 1701-1704.Stracke H., Gaus W., Achenbach U. et al. Benfotiamine in Diabetic Polyneuropathy (BENDIP): Results of a Randomised, Double Blind, Placebocontrolled Clinical Study // Exp Clin Endocrinol Diabetes. 2008. N 116 (10). Р. 600-5.Stracke H., Gaus W., Achenbach U. et al. Benfotiamine in Diabetic Polyneuropathy (BENDIP): Results of a Randomised, Double Blind, Placebocontrolled Clinical Study // Exp Clin Endocrinol Diabetes. 2008. N 116 (10). Р. 600-5.Vinik A. I., Mehrabyan A. Diabetic neuropathies // Med Clin North Am. 2 004. N88. P. 947-999.Vinik A. I., Mehrabyan A. Diabetic neuropathies // Med Clin North Am. 2 004. N88. P. 947-999.Vincent A., Calabek B., Roberts L., Feldman E. Biology of diabetic neuropathy // Handb Clin Neurol. 2013. N 115. Р. 591-606.Vincent A., Calabek B., Roberts L., Feldman E. Biology of diabetic neuropathy // Handb Clin Neurol. 2013. N 115. Р. 591-606.Visser N., Notermans N., Linssen R. et al. Incidence of polyneuropathy in Utrecht, the Netherlands // Neurology. 2015. N84 (3). Р. 259-264.Visser N., Notermans N., Linssen R. et al. Incidence of polyneuropathy in Utrecht, the Netherlands // Neurology. 2015. N84 (3). Р. 259-264.Wu J., Yang Y., Lin T., Huang Y. et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose // J Clin Endocrinol Metab. 2007. N 92. Р. 3885-3889.Wu J., Yang Y., Lin T., Huang Y. et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose // J Clin Endocrinol Metab. 2007. N 92. Р. 3885-3889.Witzel I.-I., Jelinek H., Khalaf K., Lee S. et al. Identifying common genetic risk factors of diabetic neuropathies. Front. Endocrinol., 28 May 2015. dx.doi.org/10.3389/fen-do.2015.00088.Witzel I.-I., Jelinek H., Khalaf K., Lee S. et al. Identifying common genetic risk factors of diabetic neuropathies. Front. Endocrinol., 28 May 2015. dx.doi.org/10.3389/fen-do.2015.00088.Ziegler D., Ametov A., Barinov A., et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy // The SYDNEY2 trial. Diabetes Care. 2006. N 29. Р. 2365-2370.Ziegler D., Ametov A., Barinov A., et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy // The SYDNEY2 trial. Diabetes Care. 2006. N 29. Р. 2365-2370.Ziegler D. Diabetic Neuropathy. German Diabetes Association: Clinical Practice Guidelines // Exp Clin Endocrinol Diabetes. 2014. N 122. Р. 406-15.Ziegler D. Diabetic Neuropathy. German Diabetes Association: Clinical Practice Guidelines // Exp Clin Endocrinol Diabetes. 2014. N 122. Р. 406-15.

The authors declare that there are no conflicts of interest present.